Study of the in vitro and in vivo metabolism of 4-HO-MET

Forensic Sci Int. 2018 Sep:290:103-110. doi: 10.1016/j.forsciint.2018.06.037. Epub 2018 Jul 4.

Abstract

4-Hydroxy-N-methyl-N-ethyltryptamine (4-HO-MET) is a new psychoactive substance (NPS) of the chemical class of tryptamines. It shows structural similarities to the endogenous neurotransmitter serotonin, and is a serotonergic hallucinogen, affecting emotional, motoric, and cognitive functions. The knowledge about its biotransformation is mandatory to confirm the abuse of the substance by urine analysis in forensic cases. Therefore, phase I metabolites were generated by the use of the pooled human liver microsomes (pHLM) in vitro model and analyzed by high-performance liquid chromatography high-resolution tandem mass spectrometry with information-dependent acquisition (HPLC-IDA-HR-MS/MS). Furthermore, three authentic urine samples was analyzed and results were compared: 12 different in vitro and 4 in vivo metabolites were found. The predominant biotransformation steps observed in vitro were mono- or dihydroxylation of 4-HO-MET, besides demethylation, demethylation in combination with monohydroxylation, formation of a carboxylic acid, deethylation, and oxidative deamination. In vivo, monohydroxylation, and glucuronidation were detected. A metabolic pathway based on these results was proposed. For the analysis of urine samples in forensic cases, the N-oxide metabolite and the HO-alkyl metabolite are recommended as target compounds, besides the glucuronides of 4-HO-MET and the parent compound 4-HO-MET itself.

Keywords: 4-HO-MET; HPLC-IDA-HR-MS/MS; Human liver microsomes; Metabolism; NPS; Synthetic tryptamine.

MeSH terms

  • Biotransformation
  • Chromatography, Liquid
  • Designer Drugs / pharmacokinetics*
  • Female
  • Forensic Toxicology
  • Humans
  • Male
  • Microsomes, Liver / chemistry
  • Psychotropic Drugs / pharmacokinetics*
  • Psychotropic Drugs / urine
  • Tandem Mass Spectrometry
  • Tryptamines / pharmacokinetics*
  • Tryptamines / urine

Substances

  • Designer Drugs
  • Psychotropic Drugs
  • Tryptamines